SYK: Supply challenges persist in key segments, but strong capital demand and new products support growth
Category: Business
Share
Archive
Like
Guidance for 2024 remains unchanged despite ongoing supply challenges in peripheral vascular and joint replacement segments, with robust performance in capital and trauma businesses offsetting softness. Management is confident in long-term growth, margin expansion, and the ability to regain share as supply issues resolve.
Based on Stryker Corporation [SYK] Wells Fargo 21st Annual Healthcare Conference Audio Transcript — Sep. 8 2026
A note on cookies
Newshunt uses essential cookies to keep you signed in and to remember your language and country, so the site works the way you expect. With your permission, we'd also like to use analytics cookies to understand how people use Newshunt and improve it over time.
Accepting only affects analytics. To learn more, view our Privacy Policy or Terms & Conditions.
(0)Comments